|
Powered by Cell Signaling Technology |
Site Information |
---|
VVALPQVkQEkADtQ SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 3144812 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on MBD1: | |
Effects of modification on biological processes: | |
Inhibit interaction with: |
References | |
---|---|
Tammsalu T, et al. (2014) Proteome-wide identification of SUMO2 modification sites. Sci Signal 7, rs2
24782567 Curated Info |
|
Possemato A (2010) CST Curation Set: 9355; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: smK
Curated Info |
|
Lyst MJ, Nan X, Stancheva I (2006) Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBO J 25, 5317-28
17066076 Curated Info |